Britannia Life Sciences Inc. (CSE:BLAB)
Canada
· Delayed Price · Currency is CAD 0.110
+0.010 (10.00%)
At close: Mar 6, 2026
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of CAD 17.85 million as of March 6, 2026. Its market cap has increased by 83.33% in one year.
Market Cap
17.85M
Enterprise Value
2.21M
Revenue
157.68K
Ranking
n/a
PE Ratio
2.25
Stock Price
0.11
Market Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 41.95M to 17.85M, a decrease of -57.45%. That is a compound annual growth rate of -18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 17.85M | 22.22% |
| Dec 31, 2025 | 14.60M | 12.50% |
| Dec 19, 2024 | 12.98M | 6.67% |
| Dec 29, 2023 | 12.17M | 7.14% |
| Dec 30, 2022 | 11.36M | -60.48% |
| Dec 31, 2021 | 28.74M | -31.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemostemix | 16.60M |
| Lobe Sciences | 16.17M |
| Rapid Dose Therapeutics | 18.25M |
| Quantum BioPharma | 19.94M |
| Innovotech | 13.26M |
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 11.44M |
| Thiogenesis Therapeutics | 25.92M |